Isomorphic Labs rethinks drug discovery with no labs, just AI
Endpoints News - 12-Dec-2024This aims to reduce development time but faces challenges in proving real-world success
Isomorphic Labs
Discovering new drugs with AI-first approach
Isomorphic Labs is a new Alphabet company established with the mission to use AI to accelerate drug discovery, and ultimately, find cures for some of humanity’s most devastating diseases. Headquartered in London.
This venture is named 'Isomorphic' based on the idea that there may a common structure between biology and information science. As pioneers in the emerging field of ‘digital biology’, we look forward to helping usher in an amazingly productive new age of biomedical breakthroughs.
Isomorphic Labs Leadership Team
- Demis Hassabis, Founder and CEO
- Colin Murdoch, President
- Miles Congreve, Chief Scientific Office
- Max Jaderberg, Chief AI Officer
- Sarah Korman, General Counsel
- Beverley Mallon, Chief People Officer
- John Strafford, Vice President of Business Development
- Sergei Yakneen, Chief Technology Officer
Isomorphic Labs Scientific Advisory Board
- Jennifer Doudna
- David MacMillan
- Paul Nurse
- Menelas Pangalos
- Venki Ramakrishnan
Visit website: https://www.isomorphiclabs.com/
Details last updated 06-Feb-2022
Mentioned in this Resource
David MacMillan
University Professor of Chemistry at Princeton University, winner of Nobel Prize in Chemistry
Menelas Pangalos
Formerly Executive Vice President at AstraZeneca, Board member at Isomorphic Labs, The Francis Crick Institute, and others
Paul Nurse
Chief Executive Officer at Francis Crick Institute, winner of Nobel Prize in Physiology or Medicine
Isomorphic Labs News
New AI model AlphaFold 3 predicts DNA and protein structures accurately
The Register - 09-May-2024Though it has some flaws, it holds promise for future scientific advancements
Isomorphic Labs partners with Eli Lilly, Novartis to use AI in drug discovery
pharmaphorum - 08-Jan-2024Their AlphaFold engine models proteins could lead to faster and more effective treatments
Isomorphic labs teams up with pharma giants for AI-driven drug discovery
TechCrunch - 07-Jan-2024Eli Lilly and Novartis invest in cutting-edge AI to accelerate the search for life-saving treatments
Isomorphic Labs on an expansion drive for its AI-enabled drug discovery
Financial Times (FT) - 03-Dec-2022Plan is to build a generic platform then work with major pharma companies to take them to market
Google's parent company launched Isomorphic Labs to discover new drugs using AI
TechCrunch - 04-Feb-2022Building from Deepmind's AI research, Isomorphic promises medical breakthroughs
